Implication of ZNF217 in accelerating tumor development and therapeutically targeting ZNF217-induced PI3K-AKT signaling for the treatment of metastatic osteosarcoma

We previously identified ZNF217 as an oncogenic driver of a subset of osteosarcomas (OSAs) using the Sleeping Beauty (SB) transposon system. Here, we followed up investigating the genetic role of ZNF217 in OSA initiation and progression through establishment of a novel genetically engineered mouse m...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Cancer Ther
Hlavní autoři: Smeester, Branden A., Draper, Garrett M., Slipek, Nicholas J., Larsson, Alex T., Stratton, Natalie, Pomeroy, Emily J., Becklin, Kelsie L., Yamamoto, Kenta, Williams, Kyle B., Laoharawee, Kanut, Peterson, Joseph J., Abrahante, Juan E., Rathe, Susan K., Mills, Lauren J., Crosby, Margaret R., Hudson, Wendy A., Rahrmann, Eric P., Largaespada, David A., Moriarity, Branden S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290861/
https://ncbi.nlm.nih.gov/pubmed/32999043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0369
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky